The most common complications of cochlear implantation are jlap necrosis, comp ressed or improperly pla ced electrodes, and fa cial nerve injury, paresis, or stimulation. We report on thre e recent complications expe rienced at ou r instltution: 1) a jlap isch emia and partialthickn ess necrosis without infection or device exposure, 2) fa cial nerv e stimulation, which was managed with a new pro gramming technique, and 3) a postimplant cholesteatoma iil a patient with chronic eustachian tube dysfunction that required reop eration and explantation. We discuss the pathophysiology, likely etiology, and recomm endations for managem ent of these complications.
Introduction
Since 1988, several reviews':" of complications associated with cochlear implantation have been publi shed, including a comprehensive repo rt by Hoffman and Cohen in 1995. 5 The data for their paper were provided by Cochlear Corp ., which markets the Nucleu s 22-channel device; Advanced Bionic s, which markets the Clarion multichannel implant ; and Smith Nephew Richard s, which markets the Ineraid prosthesis. Cochlear Corp. provided data on 4,969 implants , Advanced Bionics on 167 patient s, and Smith Nephew Richards on 172 patients.
Flap-related problems continue to be the most common complications, although theirrates have fallen from 5.44 % in 1988 1 to 2.79 % in 1995. 5The incidenee of compressed/ misplaced electrodes has also declined, from 1.74 to 1.18%, as has the incidenee offacial paresis , from 1.74 to 0.56%.1,5 (The data in this paragraph pertain only to the Nucleus 22-channel dev ice.)
The lowering of complication rates is no doubt the result of better training in cochlear implant surgery and more experience among surgeons. Neverth eiess, flap neero sis, which is still the most frequently encountered complication, is feared by all surgeons because it can necessitate explantation. Only a few papers have addressed this complication as a single issue .??In their 1988 paper, Cohen et al reported that onlyone patient in a serie s of 459 implants (0.22%) experienced facial nerve stimulation following electrode activation.' Apart from the fact that this problem required expl antation , no further detail s were provided about the anatomic status of the cochlea or the facial nerve and fallop ian canal. In 1995, Hoffman and Cohen reported facial nerve stimulation in 101 of 4,969 implants (2.03 %).5What were the cau ses and underlying mechanisms? Only a few papers have addressed them, and in nearly all instances, the mechanisms propo sed were specul ative.!'"!"
The incidenee and management of postimplant acute otitis media, persistent middle ear effusions , and postimplant cholesteatomas have not been substantively discu ssed in the literature. In 1991, Cohen and Hoffman made brief mention of an unpubl ished 1989 Cochlear Corp. survey on postimplant otitis media.' The parents of 133 children were surveyed, and 17 children (12.8%) were reported to have had at least one episode of acute otitis media . No adverse sequelae were noted . No mention was made of how the surve y was conducted. Luntz et al conducted a study of 50 children who had rece ived a cochlear implant and found that acute otitis media developed in only eight of these children (16 %) , all of whom already had a history of the disease. " From data provided to Hoffman and Cohen by Smith Nephew Richards , only one patient out of 172 (0.58%) developed a postimplant secondary chole steatoma.' No mention was made of the patient' s age (i.e., adult or ehiId) or how the case was managed. In a review of 50 cochlear implants published in 1995, Lloyd et al noted a postimplant retraction pocket cholesteatoma in one patient (2%). 16 From this review , it is clear that although complications assoc iated with cochlear implan tation have been catalogued numerically, there is a paucity of detailed reports describin g them clinically. Such informat ion would help the surgeo n avoid these compl ications. Th e purp ose of this paper is to describ e the clinical fea tures and management of three postim plant co mplica tions,
Case reports
Case 1. A 57-year-old woman gave a history of bilateral progressive sensorineural hearing loss , which culminated in deafness wit hin 5 mont hs. She also had a history of severe rheumatoid arthritis, asthma, and ane mia of unknown origin. She had undergone multiple fundoplications for weight loss. The wo man und erw ent a right cochl ear implantation with a Nucl eus 22-c hannel device. A postaur icul ar Cshaped incision was made, and the integrity of the superficia l tempora I artery and the occ ipital artery was maintained. The procedure was weil tolerated , but on the second postoperative day, the patient was noted to have a moderate degree of venous congestion, limited to the Cshaped flap (fig ure I A). The area of co nges tion dem arcated over the next 3 days to approximately 2 x 3 cm, and then it progressed to epidermolys is. Th e patient was disch arged home on postoperative da y 3 and was prescribed ora l antibiotics and local wo und care in the form of a 0.9% NaCI so lution wet-to-dry dressing change three times a day. An esc ha r that formed on the affe cted ski n was left in place as a bio logic dressing (figure IB ).
The wound responded we il to local ca re, did not beco me infected, an d gradually re-ep ithelialize d. At no time dur ing the posto perative course was the dev ice exposed or at risk . The wound was j udge d to be closed and health y on postoperative day 38 .
Case 2. A 73-year-old woman with a history of glaucoma, coronary artery disease, and hypoth yroidism reported that she had ex perienced a gradually worsening right -sided sensorineural hearing loss of unknown etio l- ogy ove r many years. At the time of her visit to our institu tion, the patient was unaidable. She had already lost the hearing in her left ear follow ing a left radica l mastoidectomy at anot her institution.
Th e patient therefore underwent a right coc hlear implantation with a Nucl eus 22-channel device. Sh e was discharged home in good condition on postoperative day 2, and her sub sequ ent wound healin g was uneventfu!. Upon aetivating the impl ant, how ever, she felt a vigorous, pain ful stimulation of all branches of the ipsilateral facial nerve.
Heriniti al programming mode was bip olar+ I (BP+I). In the BP+ I co nfig uration, the electrode that is more distal in the apical direction to the active electrode is skipped, and the next ap ical electrode is used as the indifferent one. As the dis tance betwee n the active and indi fferent electrodes increases, the current den sity decreases, which lessens the possibilit y of fac ial nerve stimulation. Lengthen ing the distance, there fore , result s in a need for fewer electrode pairs and , hen ce, deereases the frequ ency specificity.
Following the incid ent of facial nerve stimulatio n, the device was reprogramm ed for every mode up to BP+5. Stiil, the facial twi tching persisted. We the n obtained a co mputed tomograph ic (CT) sean of the temporai bone. CT showed that the mid basa l electrodes had co me into co ntact with the labyrinth ine seg ment of the facial nerve ( figure 2A ). We deferred further attempts to reprog ram for 2 month s in the hope that fibrous tissue wo uld grow betw een the electrodes and the facial nerve. Unfortunatel y, even afte r 3 months, she continued to experi ence facial twitchin g in res ponse to auditory stimulation.
At about the same time, Coc hlear Corp. infor med us of a new programming software it had developed. The Variable Mode Stim ulation (DPS version 6. I25) device allows the audio logist to specify which of the reference electrodes will be active and which will be ind ifferent in implant with the variab le modes, we were able to widen the stimu lation mode on all electrode pairs by changing the indifferent eleetrode. For examp le, with the standard BP+5 mode , eleetrodes 8, 7, and 6 had to be eliminated beeause of the faeial nerve stimulation. However, with the variable mode , we were able to sueeessfully use wider bipolar modes in an attempt to reduee the amount of eurrent beIow the level of nona uditory sensations. We eomb ined three variable modes to avoid the faeial nerve stimulations eaused by eleetrodes 8, 7, and 6 in the example above. These three modes were BP+7 (erea ted by separating the indifferent eleetrode from the aetive eleetrode by a distanee of7 eleetrodes), BP+8 (separating the indifferent from the aetive by a distanee of 8 eleetrodes), and BP+9 (separating the two by 9 eleetrodes). For eleetrode 8, the indifferent electrade was set to 16 (BP+7) ; for eleetrode 7, the indifferent elee trode was set to 16 (BP+8); and for eleetrode 6, the indifferent eleetrode was set to 16 (BP+9). We were thus able to reprogram all eleetrodes witho ut stimulating the faeial nerve, while stiIl praviding a true auditcry sensation (exeept for the most apiea l eleetrodes). We were able to give the patient 14 eleetrade pairs , eompared with none prev iously.
Immediately after pragramming in the variable mode , the patient was able to deteet speeeh, diser iminate differenees in word pairs (as show n by a score of 62 % on the Coehlear Corp . vowel identifieation test), and identify common spondee words in a closed set (score: 74 % on the --and it goes to work in 15 
Discussion
Flap necrosis. As mentioned, flap neerosis is the most common eomplication of eoe hlear implant surgery. However , only a few reports have addre sse d the iss ue substa ntively. ?? From our review of the literature, we foun d that in most patients who experieneed flap neerosis, it oceurred some weeks or months after surgery and res ulted in de vice extrusion.F -'? Neerosis or infection of the skin edge has been described in onlyone report.' It is possible that flap-edge necrosis has not been repor ted mo re ofte n becau se Cohe n and Hoffman categorized it as a minor complica tion .' Th e patient described in case I falls into the minor category because no secon dary surg ical intervention was necessary. But regardless of whe ther flap necrosis is a major or to have an external otitis with a thickened, mobile tym pa nic membrane. Thi s reso lved with sys temic antibiotic therapyand the instillation of antib iotic-steroid eardrops. Resolution of the inflammation was confirmed by microscopic examination. The tympa nic mem brane was intact, mobile, and in the annular plane . One month later, the patient again returned with a postaur icul ar skin breakd own and expos ure of the impl ant ed device. Th e faciopl astic se rv ice was co ns ulted, and the problem was managed with a loea l advancement flap.The patient tolerated the procedure weil, and she was disch arged home on the seco nd postoperative day . Afterthe wound was co mpletely healed, reactivation of the device failed. CT of the temporai bone showed a discontinuity of the stimulating wire . Clearly, the stimulating wire had been cut during the flap ad vancement procedure. The patient was retur ned to the operating room forexp loration, and a large eholes teatoma was found in the mas toid segment. The neek of the eho lesteatoma was loeated in the faeia l reeess. Upo n viewi ng the tym panic membrane through the external auditcry ea nal, it appeared to be a posterior-superior retractio n pocke t cholesteato ma. The eoe hlear deviee was explanted, and a radiea l mastoideetom y was performed. Postoperatively, the patient had no drain age from the operated ear. Beeau se this patient' s hearing had been suboptimal eve n whe n the impl ant was workin g, and beca use of cos t considerations, her parent s eleeted not to implant the opposi te ear, but to continue her developm ent with a hearing aid and sign language. when seored for sentences ee rreet rather than key words correct, However, after some weeks ofsueeessful use, the patient bega n to be troubl ed agai n by faeia l stimulatio n and had to stop using the implant. Case 3. We saw a 9-year-old girl who had been born at 26 weeks' ges tation and who had been diagnosed as deaf durin g her stay in the neonatal intensive eare unit. She had been on meeh anieal ventilation in the ICU for 4 month s. She had also undergone two eardiothoraeie surgieal proeed ures and numerou s blood transfusions. During subsequent years , the girl had had several sets of pressureequalizing (PE) tub es inserted .
Preoperati vely, we observed that the middle ear on both sides was we il aerated, and her tym panie membranes were in the annular plane. A Nuc leus 22-ehannel device was impla nted in the left ear. The skin flap was 6 mm thiek and was handled gen tly during surgery. The facial reeess was opened with a diamond bur, without eausing inj ury to the annu lar ligament orthe ehorda tympani. The incus was disartieulated and removed for access. The posterior eanal wall was left intaet and not thinned exeessively. The procedure was weil tolerated and wit hout operative co mplicat ions. Sub sequ ently, the deviee was programmed and was funetional.
Seve n months later the patient returned with severe ear pain and purulent otorr hea on the impl anted side . On exa mination und er the mieroscope, the patient was noted minor complication , it is one that is feared because it can necessitate explantation of an expensive device. A good understanding of flap phy siology is therefore critical because it will help in 1) preoperatively defini ng risk facto rs that have a negative impact on flap performance and 2) impro ving operative techn ique. Daniel and Kerrigan have reviewed the pathophysiology of skin flaps in some detail. 18 Survival of a surgical skin flap depends on anatomic, neural, metabolic, and horm onal factors . During elevation of the flap , cutaneous blood vesseis and sympathetic nerves are severed. Th is results in a significant decrease in blood flow , not only beca use of the decreased vascu lar supp ly, but also because of the release of vasoconstricting neurotransmitters from the severed nerve end s. Glucose, oxygen, and cycIic AMP levels fall dramatically in the ischemic portio n of the flap as anaerobic metabolism and the production of lactate and tox ic superoxide radicals increaseo The se effects alone can cause an irreversible ischemia in the distal end of a poorly desig ned flap within 12 hours. Tissue that surviv es this initial insult will respond wit h humoral vasodil ator s, such as prostaglandins and histamine, and the flow to the ischemic areas will grad ually increaseo Metabolic factors in an ischemic surgical skin flapsuch as hypercapnia, hypoxia, acidosis, and interstitial potassi um-all have a primarily vaso dila ting effect, and they will reverse the low perfusion state during the following 24 to 48 hours. During this same time frame, there is also a degradation and depletion of sympat hetic vasoconstrictors that can result in a gradual increase in flow. In patien ts whose nutritional status is good , adeq uate collateral circu lation is restored in 4 or 5 days. Factors that can con tribu te to poor flap performance incIude dia betes, vitamin deficiencies (A, B complex, and C), anemia, poor nutrition or protei n depletion, pro longed hospitalization, stero id or other immunosuppressive therapy , and nicotine addiction.
The flap complication rate of 2.79 % compares favorably with published comp lication rates for other neurosurgical procedures. In 1982, Stern estimated that the scalp wound com plication rate following major neuro surgical procedures was 6%.1 9 The neurosurgery literature describes a number of measure s to avoid scalp flap necrosis. Wilkins writes that the width of the base of a scalp flap shou ld be wider than the length of the flap in order to ensure a good vascular and lymphatic supply." Allen and Johnston belie ve that I) optimal elosure of a scalp f1 ap requires two layer s, 2) that f1 aps must not be closed under tension , so as to avoid ischemia at the suture line, and 3) that the elos ure of the galea apon eurotica should be separated fro m a second suture line through denni s." They suggest that minim izin g scalp f1apnecrosis depend s on I) careful hand lin g of the flap intrao peratively (excess manipulation or prolonged angulatio n after reflection can cause ischem ia), 2) not using Raney c1ips (to avoi d skinedge ischemi a), 3) ass uri ng a goo d vasc ular supply by closi ng the wound with min imal ten sion (with the use of relaxing incision s and f1ap unde rcu tting if nece ssary), and 4) avo iding tight dressin gs postop erati vely.
Even when all these recommendation s are follow ed and risk facto rs are accounted for, the sca lp flap used in earlier yea rs for cochlear implantation (C-s haped, postaur icular ) is at particul ar risk because undern eath it Iies a large fore ign body. Furthermore, the thickness of the flap ca nnot be greater than 6 mm ; otherwise the externa l device will not adhere to the skin by magnetic attraction. If the thinning of the f1ap reac hes the level of the hair follic les, the dev ice is at risk for extrus ion." Th e distance of the imp lanted device from the edge of the incision is also crit ical.
The patient described in case I ex perienced on ly epidermolysis of a port io n of the operati ve f1 ap. At no time was the device expo sed , infected , or at risk . There were no intraoperative eve nts or fac tors that wo uld have indicated that her f1 ap was at risk. Th e C -shaped f1 ap was large, it had a broad base that spared both the occi pital and superficial temp oraI arteries, it did not require thinn ing, and it was handl ed gently. No Raney clips were used . Th e patient responded we il despite the fac t that she had a numb er of risk fac tors for" complications: she was a smoker, and she had a known aut oi mmune condition, anem ia, and poor nutr itional status as a res ult of her multiple fundo plic atio ns. Furtherm ore, she was on longterm stero id therap y.
Facial nerve stimulation. Hoffm an and Cohen reported 101 cases of fac ial nerve stimulation (83 adults and 18 children) followi ng 4,969 cochlear implant ations, for a complication rate of2. 03 %. 5 Our revi ew of the literature revealed that faci al nerve stimulatio n occ urred in 45 patients described in eight papers.IO -14.22-24 Of these 45 pub lished cases, six occ urred in pat ients implanted with single-channel devi ces" and 39 occu rred with multipl echa nnel devic es of various design s. Th e presumed etiology of the stimulation is the distributi on of current from the elec trode array to the facia l ner ve. Niparko et al have prop osed that with single-c hannel devices, the relative ly large current field distribution is the ca use of facial nerve stimulation.JO In con trast, Langm an et al pub lished a case study in whic h a sing le-channel impl ant did not ca use faci al ner ve stimulation, but a subse quent 22-chann el replacement did ." 9 18 Fou r gro ups of autho rs have observed a co rrelatio n bet ween fac ial ner ve stimu lation and otosc lerosis.! "!' Ma rsh et al proposed that the spongiotic bone of otosclerosis might decrease imp ed ance and result in a current spread from the electrode array to the fallopi an canal." Cochlear otosc leros is might be a factor in so me cases, but it is unlikely to be the ca use in all cases. Certainl y, the patient desc ribed in case 2 did not have coc hlea r otosclerosis . Shea and Domico described a patient in whom basal elec trodes stimulated the descending mastoid segment of the facia l nerve." This stimulation was so painful and intr actable that the patient was forced to stop usin g the device and requested an expl antation. During the exp lantation , the surgeons noted the developm ent of adhes ions that represented an appare nt inflammatory respon se to the elec trode array ; these adh esion s were the Iikely source of current shunt.
Th e patient in case 2-although she did not have otosc lerosis or any ot her infla mmatory co nd itio n of the otic ca psule-experience d severe, pain ful fac ial ner ve stimulatio n upon ac tiva ting her device. Th e stimulatio n was most seve re at the midb asal electrodes (8, 7, and 6) . Radi ographic studies indica ted that these three elect rodes had co me into contac t with the labyrinth ine seg ment of the facial nerve. The problem was solved by reprogramming the device in a variable mode andchanging the indifferent electrode , using wider bipo lar mode s to reduce the levels of curre nt. After the device had been reprogrammed, the patie nt was able to use 14 elec trode pairs (only the most apical electrodes could not be programm ed).
In tim e, she was able to identify so me wo rds and sentences in an open se t. However, because of a rec urre nce of persistent facial nerve stimulation, she was forced to stop usin g the device.
In most cases of facial ner ve stimulation reported in the literature, deprogramming of the offending electrodes was required . Notable exceptions were five cases of spontaneous resolut ion with out treatment,10.12 two of which occ urred in pati e nts with sing le-c ha nne l devices.'? Langm an et al reported a case of stimulatio n that was successfully treated with inj ections of botulinum toxin." Thi s strategy had an adva ntage in that it did not require the deacti vation of the elec trodes, ther eby allow ing the patient to experience the full benefits of the cochlear implant. At the time the patient described in case 3 was implanted , she had been free of middle ear disease. Her cholesteatoma developed during the 9 month s between the time the micro scopic examination showed an intact tympanic membra ne in the annular plane and the time of her retu rn to our institution at the onset of a breakdown of the postauricular skin. Thu s, it would be inappropriate to categorize this as an iatrogeni c cholesteatoma. The ehiId had a long history of an underaerated middle ear, and she had required multiple sets of PE tubes , indic ating a prob able eustachian tube dysfunction. Her margin al eustachi an tube .function had become critically diminished sometime after the micro scopic examination, and we believe this led to the formation of the posterior-superior quadrant cholesteatoma. Obviously, this ehi Id should have rece ived more frequent otologic examinations. We can probabl y become more sensitive to the fact that a pati ent needs closer observation if the preoperative CT shows poor pneumatization of the mastoid or if there is a histor y of multiple PE tube insertions.
When a cholesteatoma doe s develop , what should we do with the impl ant? Should we explant it and implant the oppo site ear? Should we reimplant it in the same ear after the disease has been eradicated? The latter option is possible when the middle ear is obliterated and the external auditory canal and eustachian tube are blocked. However, the chanee that a dangerou s complication will develop many year s later is a distinet possibility (as pointed out by Donnelly et aP5), so careful and frequent imaging of the ear is a prerequ isite . The parent s of our patient did not want any further surgery, so we explanted the device and completed a radica l mastoid ectom y.
In conclusion, we would like to emphasize three point s: 1) A careful revi ew of all risk factors for poor flap performance must be made in every patient who is selected for cochlear implantation. 2) Every case of facial nerve stimulation following the activation of a cochlear device should be investiga ted with a bon e-window CT in the axial and coron al plane s to determ ine the relation ship of the electrode arra y to the facial nerve. Currently , we do not know the exact cause of facial nerve stimulation. If a correlation between facial nerve stimulation and cochlear otosclerosis is to be confi rmed , we will need multicenter studies. Meanwhile, the use of the Var iable Mode stimulation (DPS version 6.125 ) device can prevent facial nerve stimulation and at the same time allow for auditory input. 3) We need longitudin al multi center studies on the incide nee of middle ear disease in implanted children. Such investigations could provide us with guidelines for managing child ren who have kno wn eustachi an tube dysfunction. For Volume 78, Number 12 the time being , however, we feel that all children need frequent and careful followup over a long period of time .
